Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis

References

• Tbahriti HF, Meknassi D, Moussaoui R, et al. Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol. 2013;2:31–37.
   PubMedGoogle Scholar
• Stompor T, Pasowicz M, Sullowicz W, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003;41:203–211.
   PubMed Web of Science ®Google Scholar
• Borazan A, Ustün H, Ustundag Y, et al. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels. Mediators Inflamm. 2004;13:201–204.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem. 2001;47:28–30.
   PubMed Web of Science ®Google Scholar
• Kaylan N. Kardiyovasküler bir risk faktörü olarak CRP. AII Konseyi Bülten. 2005;9:1–4.
   Google Scholar
• Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2169–2172.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Chang J, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by antiatherosclerosis drugs. Circulation. 2000;103:2531–2534.
   Web of Science ®Google Scholar
• Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105:1890–1896.
   PubMed Web of Science ®Google Scholar
• Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–919.
   PubMed Web of Science ®Google Scholar
• Barros AF, Moraes C, Pinto MB, Lobo JC, Mafra D. Is there association between acyl-ghrelin and inflammation in hemodialysis patients? J Bras Nefrol. 2013;35:120–126.
   PubMedGoogle Scholar
• Striz I, Trebichavsky I. Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245–253.
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–1397.
   PubMed Web of Science ®Google Scholar
• Yang F, Khin LW, Lau T, et al. Hemodialysis versus peritoneal dialysis: A comparison of survival outcomes in south-east asian patients with end-stage renal disease. PLoS One. 2015;10:1–10.
   Google Scholar
• Helal I, Smaoui W, Hamida FB, et al. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Saudi J Kidney Dis Transpl. 2010;21:59–62.
   PubMedGoogle Scholar
• Rysz J, Banach M, Cialkowska-Rysz A, et al. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol. 2006;3:151–154.
   PubMed Web of Science ®Google Scholar
• Gad MZ, El-Mesallamy HO, Sanad EF. hsCRP, sICAM-1 and TAFI in hemodialysis patients: linking inflammation and hypofibrinolysis to cardiovascular events. Kidney Blood Press Res. 2008;31:391–397.
   PubMed Web of Science ®Google Scholar
• Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007;27:15–26.
   PubMed Web of Science ®Google Scholar
• Urquhart BL, House AA. Assessing plasma total homocysteine in patients with end-stage renal disease. Perit Dial Int. 2007;27:476–488.
   PubMed Web of Science ®Google Scholar
• Erdemir G, Ozkan TB, Ozgur T, et al. Helicobacter pylori infection in children: Nutritional status and associations with serum leptin, ghrelin, and IGF-1 levels. Helicobacter. 2015. [Epub ahead of print]. doi: 10.1111/hel.12288.
   PubMedGoogle Scholar
• Cobanoglu N, Galip N, Dalkan C, et al. Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma? Multidiscip Respir Med. 2013;8:6225.
   PubMed Web of Science ®Google Scholar
• Shore SA, Schwartzman IN, Mellema MA, et al. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol. 2005;115:103–109.
   PubMed Web of Science ®Google Scholar
• Matsuda K, Nishi Y, Okamatsu Y, et al. Ghrelin and leptin: A link between obesity and allergy? J Allergy Clin Immunol. 2006;117:705–706.
   PubMed Web of Science ®Google Scholar
• Guler N, Kirerleri E, Ones U, et al. Leptin: Does it have any role in childhood asthma? J Allergy Clin Immunol. 2004;114:254–259.
   PubMed Web of Science ®Google Scholar
• Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of ob gene, promotes angiogenesis. Circ Res. 1998;83:1059–1066.
   PubMed Web of Science ®Google Scholar
• Parhami F, Tintut Y, Ballard A, et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001;88:954–960.
   PubMed Web of Science ®Google Scholar
• Bouloumie A, Marumo T, Lafontan M, et al. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999;13:1231–1238.
   PubMed Web of Science ®Google Scholar
• Dervisevic A, Subo A, Avdagic N, et al. Elevated serum leptin level is associated with body mass index but not with serum C-reactive protein and erythrocyte sedimentation rate values in hemodialysis patients. Mater Sociomed. 2015;27:99–103.
   PubMedGoogle Scholar
• Montazerifar F, Karajibani M, Hassanpour Z, et al. Study of serum levels of leptin, C-reactive protein and nutritional status in hemodialysis patients. Iran Red Crescent Med J. 2015;17:1–5.
   Web of Science ®Google Scholar
• Szczepańska M, Szprynger K, Mazur B, et al. Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis. Perit Dial Int. 2007;27:61–66.
   PubMed Web of Science ®Google Scholar
• Bilen Y, Cankaya E, Bilen N, et al. Peritonitis incidence was correlated with duration of peritoneal dialysis rather than leptin or neutrophil to lymphocyte (n/L) ratio in peritoneal dialysis patients. Eurasian J Med. 2014;46:145–150.
   PubMedGoogle Scholar
• Yildiz G, Yilmaz A, Nur N, et al. Leptin as an inflammatory marker in dialysis patients. Turkiye Klinikleri J Med Sci. 2010;30:1482–1486.
   Google Scholar